Literature DB >> 17047894

Correlation between homocysteine plasma levels and nailfold videocapillaroscopic patterns in systemic sclerosis.

Paola Caramaschi1, Alessandro Volpe, Sabrina Canestrini, Lisa M Bambara, Giovanni Faccini, Antonio Carletto, Domenico Biasi.   

Abstract

The aim of the study is to investigate the relationship between microangiopathy as assessed by nailfold videocapillaroscopy (NVC) and plasma level of homocysteine (Hcy) in systemic sclerosis (SSc). As known, Hcy is a nonessential amino acid that interferes with normal properties of a vascular tree. Sixty patients affected by SSc (4 men and 56 women, mean age 54.6) underwent the determination of plasma Hcy level; at the same time, NVC was performed. Hcy level was also determined in 30 sex- and age-matched controls. In patients affected by SSc the plasma Hcy level was significantly higher than in healthy controls (11.8 and 6.5 micromol/l, respectively; p < 0.001). A significant correlation was found between plasma Hcy concentration and the pattern of NVC with a progressive increase from early to active and above all to late pattern (10.7, 11.8, and 17.4 micromol/l, respectively; p < 0.001). Subjects with high Hcy level (i.e., >75th percentile of Hcy level in controls and in patients considered altogether) were mostly represented in the scleroderma patients with late nailfold videocapillaroscopic pattern; the crude odds ratio was 9.0 (significant; 95% CI from 2.1 to 38.8). In conclusion, Hcy plasma level is related to microvascular involvement in patients affected by SSc; the concentration increases with the progression of the nailfold videocapillaroscopic pattern. Hyperhomocysteinemia may represent an aggravating factor among the complex mechanisms involved in scleroderma damage contributing to the injury of endothelium.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17047894     DOI: 10.1007/s10067-006-0425-9

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   3.650


  41 in total

1.  Elevated homocysteine levels in patients with Raynaud's syndrome.

Authors:  Y Levy; J George; P Langevitz; D Harats; R Doolman; B A Sela; Y Shoenfeld
Journal:  J Rheumatol       Date:  1999-11       Impact factor: 4.666

2.  European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes.

Authors:  G Valentini; A Della Rossa; S Bombardieri; W Bencivelli; A J Silman; S D'Angelo; M M Cerinic; J F Belch; C M Black; P Bruhlmann; L Czirják; A De Luca; A A Drosos; C Ferri; A Gabrielli; R Giacomelli; G Hayem; M Inanc; N J McHugh; H Nielsen; M Rosada; R Scorza; J Stork; A Sysa; F H van den Hoogen; P J Vlachoyiannopoulos
Journal:  Ann Rheum Dis       Date:  2001-06       Impact factor: 19.103

3.  Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.

Authors:  E C LeRoy; C Black; R Fleischmajer; S Jablonska; T Krieg; T A Medsger; N Rowell; F Wollheim
Journal:  J Rheumatol       Date:  1988-02       Impact factor: 4.666

4.  Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase.

Authors:  G R Upchurch; G N Welch; A J Fabian; J E Freedman; J L Johnson; J F Keaney; J Loscalzo
Journal:  J Biol Chem       Date:  1997-07-04       Impact factor: 5.157

5.  Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine.

Authors:  S R Lentz; J E Sadler
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

6.  Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis.

Authors:  K S McCully
Journal:  Am J Pathol       Date:  1969-07       Impact factor: 4.307

7.  Tissue plasminogen activator binding to the annexin II tail domain. Direct modulation by homocysteine.

Authors:  K A Hajjar; L Mauri; A T Jacovina; F Zhong; U A Mirza; J C Padovan; B T Chait
Journal:  J Biol Chem       Date:  1998-04-17       Impact factor: 5.157

8.  Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis.

Authors:  L A Harker; R Ross; S J Slichter; C R Scott
Journal:  J Clin Invest       Date:  1976-09       Impact factor: 14.808

9.  Methylenetetrahydrofolate reductase gene C677T mutation and plasma homocysteine level in Behçet's disease.

Authors:  Abdullah Canataroglu; Kahraman Tanriverdi; Tamer Inal; Gulsah Seydaoglu; Didem Arslan; Suleyman Ozbek; Fikri Baslamisli
Journal:  Rheumatol Int       Date:  2003-03-14       Impact factor: 2.631

10.  Homocysteine plasma concentration is related to severity of lung impairment in scleroderma.

Authors:  Paola Caramaschi; Nicola Martinelli; Domenico Biasi; Antonio Carletto; Giovanni Faccini; Alessandro Volpe; Marcello Ferrari; Cinzia Scambi; Lisa Maria Bambara
Journal:  J Rheumatol       Date:  2003-02       Impact factor: 4.666

View more
  1 in total

1.  Plasma Homocysteine is Not Related to the Severity of Microangiopathy in Secondary Raynaud Phenomenon.

Authors:  Vincenzo Jacomella; Monika Wasila; Marc Husmann; Gabriela Gitzelmann; Thomas Meier; Beatrice Amann-Vesti
Journal:  Open Rheumatol J       Date:  2011-11-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.